Trending Down-0.1500 (-0.3073%)
  • Bid / Lots
    48.0000/ 2
  • Ask / Lots
    49.0000/ 1
  • Open / Previous Close
    48.6100 / 48.8200
  • Day Range
    Low 48.3100
    High 48.6700
  • 52 Week Range
    Low 42.6300
    High 55.7200
  • Volume
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • May 14, 2024

  • May 13, 2024

      Show headlines and story abstract
    • 1:59PM ET on Monday May 13, 2024 by Dow Jones
      Companies Mentioned: NVAX, SNY

      By Ben Glickman

      Shares of Novavax continued their ascent on Monday, adding to gains from last week after the company announced a licensing deal with Sanofi.

      The stock was up 50% to $13.31 in afternoon trading, reaching its highest intraday level since December 2022. Shares roughly doubled on Friday following the news, and are now up more than threefold in the last three months.
    • 12:27PM ET on Monday May 13, 2024 by MT Newswires
      Companies Mentioned: GME, INTC, JNJ, MSFT, BKNG, SNY, APO, HES, AMZN, BHP, SQSP, KVUE, CVX
      12:27 PM EDT, 05/13/2024 (MT Newswires) -- The major US indexes were higher at midday Monday as investors ready themselves for a consequential inflation data release on Wednesday. In company news, shares of GameStop (GME) soared in premarket and ear...
    • 10:00AM ET on Monday May 13, 2024 by Dow Jones
      Companies Mentioned: SNY, FULC

      10:00 ET -- Fulcrum Therapeutics is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. Fulcrum Therapeutics has licensed the international rights to its proposed treatment for a rare, genetic muscular disorder to France's Sanofi in a deal potentially worth more than $1 billion to the clinical-stage biopharmaceutical company. Fulcrum said it will work with Sanofi on the development and commercialization of losmapimod. The agreement gives Sanofi exclusive commercialization rights for losmapimod outside the U.S., while Fulcrum, based in Cambridge, Mass., retains full U.S. commercialization rights. Dow Jones & Co. owns Factiva. (chris.wack@wsj.com)
    • 9:40AM ET on Monday May 13, 2024 by Dow Jones
      Companies Mentioned: JPM, MSFT, MS, PFE, SNY, ACN, AMZN, AZN
      By Mauro Orru France bagged 15 billion euros ($16.16 billion) of investment commitments from U.S. tech giants and other companies at a summit just outside of Paris, underscoring a push from President Emmanuel Macron to promote the country as an attractive destination for international investors. Microsoft, Amazon.com, Pfizer and AstraZeneca were among the top investors at the Choose France summit held at the Palace of Versailles. Dubbed France's mini Davos, the event draws high-profile executives willing to pour funds into the French economy. Macron launched the summit in 2018 during his first term as president in an effort to portray France as an attractive hub for foreign investors. In a post on X, he said this year's summit would bring in a record EUR15 billion in investments and create 10,000 new jobs. Paris has long lagged behind major financial centers like New York, but the amount in investment commitments marks an endorsement of France as a key hub for many foreign investors in Europe. The country ranks as the most attractive in Europe for international investors, according to a recent EY survey, putting it ahead of Germany and the U.K. The survey concluded that most respondents, particularly those outside of or not yet established in France, believe the country will become more attractive over the next three years. On Monday, Microsoft President Brad Smith said the tech giant would invest EUR4 billion to build out artificial-intelligence, data-center and cloud infrastructure in the country. Russ Grandinetti, senior vice president of international stores at Amazon, said the e-commerce giant would invest more than EUR1.2 billion to bolster its Amazon Web Services cloud infrastructure, logistics infrastructure and artificial intelligence. JPMorgan Chase, Morgan Stanley, Accenture and the Qatar Investment Authority also made a number of investment commitments. On the pharmaceutical front, Pfizer France President Reda Guiha said the country had developed a solid biopharmaceutical ecosystem that was benefiting innovation in fields like oncology. The maker of the Covid-19 vaccine is investing EUR500 million as part of a five-year plan to strengthen research and development. Sanofi, the French pharma group, will spend more than EUR1 billion on ramping up ramping up production capability. Meanwhile, Anglo-Swedish rival AstraZeneca said it would pour $388 million to further develop its production site in Dunkirk, northern France. Write to Mauro Orru at mauro.orru@wsj.com (END) Dow Jones Newswires May 13, 2024 09:40 ET (13:40 GMT)

Peers Headlines